Insider Activity of BONNEY MICHAEL W
Biography of BONNEY MICHAEL W
No biography is available at this moment.
No biography is available at this moment.
| 2025-08-18 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 11,250 0.0085% | $450.00 | $5.06M | -27.2% | |
| 2025-05-15 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 11,250 0.0085% | $277.71 | $3.12M | +24.14% | |
| 2023-12-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0237% | $195.00 | $5.85M | +19.33% | |
| 2023-08-03 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 6,448 0.005% | $185.38 | $1.2M | -11.01% | |
| 2019-12-04 | Bristol-Myers Squibb Company BMY | director | 176 <0.0001% | $58.90 | $10,366 | +5.26% | ||
| 2019-09-09 | Sarepta Therapeutics, Inc. SRPT | director | 2,000 0.0027% | $86.74 | $173,480 | +39.82% | ||
| 2016-03-09 | Alnylam Pharmaceuticals, Inc. ALNY | director | 4,000 0.0046% | $58.36 | $233,440 | -4.87% | ||
| 2015-05-12 | Alnylam Pharmaceuticals, Inc. ALNY | director | 4,000 0.0047% | $112.16 | $448,640 | -19.19% | ||
| 2012-03-09 | Tekla Healthcare Investors HQH | director | 650 0.0012% | $15.80 | $10,268 | +15.42% | ||
| 2012-03-09 | Tekla Life Sciences Investors HQL | director | 800 0.0027% | $13.25 | $10,604 | +17.66% |